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Abstract
Background: Tuberculosis (TB) remains a major cause of mortality in developing countries, and
in these countries diabetes prevalence is increasing rapidly. Diabetes increases the risk of TB. Our
aim was to assess the potential impact of diabetes as a risk factor for incident pulmonary
tuberculosis, using India as an example.
Methods:  We constructed an epidemiological model using data on tuberculosis incidence,
diabetes prevalence, population structure, and relative risk of tuberculosis associated with diabetes.
We evaluated the contribution made by diabetes to both tuberculosis incidence, and to the
difference between tuberculosis incidence in urban and rural areas.
Results: In India in 2000 there were an estimated 20.7 million adults with diabetes, and 900,000
incident adult cases of pulmonary tuberculosis. Our calculations suggest that diabetes accounts for
14.8% (uncertainty range 7.1% to 23.8%) of pulmonary tuberculosis and 20.2% (8.3% to 41.9%) of
smear-positive (i.e. infectious) tuberculosis.
We estimate that the increased diabetes prevalence in urban areas is associated with a 15.2%
greater smear-positive tuberculosis incidence in urban than rural areas – over a fifth of the
estimated total difference.
Conclusion: Diabetes makes a substantial contribution to the burden of incident tuberculosis in
India, and the association is particularly strong for the infectious form of tuberculosis. The current
diabetes epidemic may lead to a resurgence of tuberculosis in endemic regions, especially in urban
areas. This potentially carries a risk of global spread with serious implications for tuberculosis
control and the achievement of the United Nations Millennium Development Goals.
Background
Tuberculosis remains a leading cause of death globally. In
2005 there were an estimated 8.8 million new cases of
tuberculosis worldwide, with 1.9 million of those occur-
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ring in India[1]. Incidence of tuberculosis is greatest
among those with conditions impairing immunity[2],
such as human immunodeficiency virus (HIV) infection
and diabetes. The consequences of mismanagement of
tuberculosis in a patient with diabetes can be severe, but
there are simple and immediate opportunities for improv-
ing treatment success and reducing mortality.
The global burden of diabetes is increasing, and recent
estimates highlight the importance of this disease in
India. There were an estimated 20–30 million people in
India with diabetes in 2000 (estimates vary with study
methodology) [3,4], and projections suggest prevalence
will rise to almost 80 million people by 2030[4]. It is pos-
sible that in areas of high diabetes prevalence the impact
of this diabetes epidemic[4] on tuberculosis could be as
great as that of HIV[5], and the spread of HIV is one of the
main reasons why targets set by the Stop TB Partnership
(within the framework of the Millennium Development
Goals) will not be met in several regions, at least at current
rates of progress[6]. However, the overall importance of
diabetes as a risk factor for tuberculosis is still largely
unknown, although a recent analysis in Mexico concluded
that, in the population studied, 25% of pulmonary tuber-
culosis was attributable to diabetes[5].
Our objective was to estimate the population-level impact
of diabetes on the incidence of pulmonary tuberculosis in
India. We chose India as an illustrative example because
of its large population size, the availability of relatively
good data on both diabetes and tuberculosis, and because
the latter indicate that both these conditions are major
public health problems there. We also aimed to evaluate
the contribution made by diabetes to the higher tubercu-
losis incidence in urban compared with rural populations.
Methods
Epidemiological data
Data were extracted from the sources below, as summa-
rised in Table 1. Analyses were limited to the adult popu-
lation aged 25 years and over, as estimates of diabetes
prevalence and the relative risks of incident tuberculosis
associated with diabetes were available for this age group
only.
Diabetes Prevalence
Several sources of diabetes prevalence data are available
for India [3,7,11]; however, we used data from the Preva-
lence of Diabetes in India Study (PODIS)[3], as it was the
largest study and the only one to ascertain urban and rural
prevalences separately. PODIS is a population-based
study of 18,363 participants (9,008 men, 9,355 women)
aged ≥ 25 years in 77 centres throughout India. As PODIS
reported no sex difference in crude diabetes prevalence,
we applied the same age-specific prevalence estimates to
men and women.
Numbers of diabetes cases in India were estimated by
multiplying age-specific diabetes prevalence estimates
from PODIS by the age- and sex-specific United Nations
population estimates for India in 2000[12].
Tuberculosis Incidence
Tuberculosis case-notification data are routinely sent to
the World Health Organization from the Revised National
Tuberculosis Control Programme (RNTCP) in India. As
the programme does not yet detect all new TB cases arising
each year, the distribution of reported smear-positive
cases by age and sex was used with the WHO crude esti-
mate[1] (all ages, both sexes) of smear-positive tuberculo-
sis incidence in India in 2000 to calculate the total
number of smear-positive cases by age and sex. The per-
centage of new smear-positive cases occurring in each age/
sex group was calculated by dividing the RNTCP-reported
number of cases in each group by the total reported inci-
dence.
RNTCP notifications only include information on age and
sex for smear-positive cases. Age- and sex-specific inci-
dences of total pulmonary tuberculosis (smear-positive
plus smear-negative) were therefore calculated from the
estimates  for smear-positive incidences calculated previ-
ously. We adjusted for the difference in age distribution of
smear-negative and smear-positive tuberculosis incidence
by dividing the age- and sex-specific smear-positive inci-
dence estimates by the age-specific ratios of smear-posi-
tive to total pulmonary tuberculosis[13]. We then
calculated the overall incidence of total pulmonary tuber-
culosis in the population using the WHO estimate for
total tuberculosis incidence in the population (smear-
positive, smear-negative and extra-pulmonary)[1] and
estimating that 20% of incident tuberculosis is extrapul-
monary [14-16]. The adjusted age- and sex-specific inci-
dences were then each multiplied by the ratio of the
WHO-estimated crude incidence to the sum of the indi-
vidual incidences, to ensure that the sum of the age- and
sex-specific incidences was equal to the overall WHO
crude incidence estimate.
Relative risk for tuberculosis associated with diabetes
We obtained age-specific relative risks for the association
between diabetes and incident tuberculosis (for total pul-
monary tuberculosis and smear-positive tuberculosis sep-
arately) from a study of 814,713 Korean civil servants[17].
As separate age-specific relative risks were not reported for
men and women, we applied the same estimates to both
sexes.BMC Public Health 2007, 7:234 http://www.biomedcentral.com/1471-2458/7/234
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This is the only large-scale prospective study quantifying
the diabetes-associated risk of incident tuberculosis (reac-
tivation was excluded by baseline chest x-ray) within a sin-
gle population. The only study we found at the time of
undertaking the analyses which had been undertaken in
India had a small sample size and was cross-sectional in
design, so was less precise and could not account for tem-
poral associations and does not provide age specific rela-
tive risk estimates,[18] Recently a case control study of risk
factors for TB has been published from India in which
known diabetes was ascertained by questionnaire[19], but
this only provides a single, all ages, estimate of relative
risk.
Population
Age- and sex-specific estimates of the resident Indian pop-
ulation in 2000 were obtained from UN World Popula-
tion Prospects, 2004 revision[12].
Statistical calculations
Estimates of diabetes prevalence, tuberculosis incidence
and the relative risk of tuberculosis incidence associated
with diabetes were applied to age- and sex-specific esti-
mates of the Indian population to calculate the Attributa-
ble Fraction (Population)[20] (see below). We calculated
crude estimates of the AF(P) using data for tuberculosis
incidence and diabetes prevalence for the overall popula-
tion, as well as estimates stratified by age and sex. The
published 95% confidence intervals for the relative risks
were used to derive upper and lower bounds for the AF(P)
estimates.
We estimated the proportion of tuberculosis attributable
to diabetes among those with diabetes using the Attribut-
able Fraction (Exposed)[20] (see below) for smear-posi-
tive and total pulmonary tuberculosis. Age-adjusted
relative risks and 95% confidence intervals were calcu-
lated using Mantel-Haenszel methods.
Attributable fractions: definitions and formulae
We used the following definitions and formulae for attrib-
utable fractions.
Attributable Fraction (Population)
The proportion by which the incidence rate of the out-
come of interest (here, incident tuberculosis) in the entire
population would theoretically be reduced if the exposure
of interest (here, diabetes) were eliminated.
where Pe is the prevalence of the exposure and RR is the
relative risk for the outcome of interest.
Attributable Fraction (Exposed)
The proportion by which the incidence rate of the out-
come of interest (here, incident tuberculosis) in the
AF P
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Table 1: Summary of epidemiological data used to evaluate the importance of diabetes as a risk factor for tuberculosis in India in 2000 
for adults aged 25 years and over
UN popula-
tion 
estimate12 
(A)
Diabetes 
prevalence*3 
% (B)
Estimated 
number with 
diabetes (A × 
B)
Number of 
pulmonary 
tuberculosis† 
incident 
cases‡
Number of 
smear-posi-
tive tubercu-
losis incident 
cases‡
RR*§ for 
pulmonary 
tuberculosis†1
7 (95% CI)
RR*§ for 
smear-
positive 
tuberculosis17 
(95% CI)
Total 481,573,000 4.3 20,707,639 939,064 575,900 5.1 (1.7 – 15.8) 7.1 (2.9 – 17.2)
Women (age in 
years):
25–29 40,462,000 2.1 849,702 59,738 34,834 7.8 (1.2 – 51.3) 6.6 (1.7 – 26.6)||
30–39 68,472,000 3.5 2,396,520 91,688 54,629 10.0 (6.8 – 14.5) 6.6 (1.7 – 26.6)||
40–49 50,913,000 4.7 2,392,911 49,159 31,084 4.7 (3.6 – 6.2) 12.7 (7.4 – 21.6)
50–59 35,327,000 5.1 1,801,677 28,220 17,710 2.3 (1.8 – 2.9) 5.2 (3.1 – 8.7)
60+ 39,789,000 6.9 2,745,441 19,708 12,548 1.8 (1.1 – 2.9) 4.0 (1.4 – 11.4)
Men (age in 
years):
25–29 43,998,000 2.1 923,958 108,527 63,283 7.8 (1.2 – 51.3) 6.6 (1.7 – 26.6)||
30–39 74,585,000 3.5 2,610,475 205,044 123,081 10.0 (6.8 – 14.5) 6.6 (1.7 – 26.6)||
40–49 55,434,000 4.7 2,605,398 166,705 105,841 4.7 (3.6 – 6.2) 12.7 (7.4 – 21.6)
50–59 35,796,000 5.1 1,825,596 118,990 74,500 2.3 (1.8 – 2.9) 5.2 (3.1 – 8.7)
60+ 36,797,000 6.9 2,538,993 91,286 58,391 1.8 (1.1 – 2.9) 4.0 (1.4 – 11.4)
*Age-specific only; see Methods
†Smear-positive plus smear-negative
‡See Appendix for calculations
§Relative risk of incident TB associated with baseline diabetes
||As no RR was available for smear-positive TB incidence for the age band 25–29, the RR for 30–39 was usedBMC Public Health 2007, 7:234 http://www.biomedcentral.com/1471-2458/7/234
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exposed population would theoretically be reduced if the
exposure of interest (here, diabetes) were eliminated.
where RR is the relative risk for the outcome of interest.
Urban/rural distribution
We aimed to estimate the contribution made by diabetes
to the higher tuberculosis incidence observed in urban as
compared with rural populations. We approached this by
calculating the theoretical urban and rural tuberculosis
incidences which would be expected from the distribution
of diabetes prevalence and the diabetes-associated relative
risk for developing tuberculosis. This initially required
partitioning tuberculosis incidence across the populations
with and without diabetes. We defined the equation:
TBT = [TBND × RR × PDIA] + [TBND × (1 - PDIA)],
where TBT is the total tuberculosis incidence rate, TBND is
tuberculosis incidence in the sub-population without dia-
betes, RR is the relative risk of incident tuberculosis for
diabetes, and PDIA is the prevalence of diabetes. This equa-
tion was used to estimate tuberculosis incidence in the
populations with and without diabetes by solving mathe-
matically for TBND. Tuberculosis incidence in the popula-
tion with diabetes is TBND × RR. Theoretical urban and
rural tuberculosis incidences were then calculated using
the equation above with the urban and rural diabetes
prevalences reported by PODIS[3]. For comparison,
urban and rural tuberculosis incidences were also calcu-
lated using recent measurements of the annual risk of
tuberculosis infection[21] and Styblo's equation[22],
which has been shown to be applicable within India[23].
Prevalence of diabetes among tuberculosis patients
The prevalence of diabetes among people with tuberculo-
sis was estimated by calculating the number of tuberculo-
sis cases in the populations with and without diabetes,
and hence the percentage of cases with diabetes. Numbers
of tuberculosis cases were calculated by multiplying age-
specific estimates of tuberculosis incidence and of diabetic
and non-diabetic population size. Age-specific tuberculo-
sis incidences in the populations with and without diabe-
tes were estimated using the same methods described
under Urban/rural distribution.
All calculations were carried out in Microsoft Excel 2003.
Results
In India in 2000 there were an estimated 481,573,000
people over the age of 25 (12). Among these, 4.3%
(20,707,639) had diabetes (3), and 939,064 developed
pulmonary tuberculosis, of which 575,900 were smear-
positive and hence infectious (Table 1).
Population impact of diabetes on tuberculosis
We estimate that diabetes accounted for 14.8% (7.1% to
23.8% – upper and lower bounds based on relative risk
95% confidence intervals) of incident pulmonary tuber-
culosis in India in 2000, equating to 139,000 (67,000 to
224,000) cases. We estimated the proportion of incident
smear-positive tuberculosis due to diabetes to be 20.2%
(8.3% to 41.9%), or 116,000 (48,000 to 241,000) cases
(Table 2).
In the sub-population of the estimated 20.7 million
adults with diabetes in India, our calculations indicate
that diabetes accounts for 80.5% (39.9% to 93.7%) of the
172,000 annual incident cases of pulmonary tuberculosis,
and 85.9% (65.9% to 94.2%) of the 135,000 cases of
smear-positive (i.e. infectious) tuberculosis (Table 3).
Urban/Rural differences
Our calculations suggest that the increased prevalence of
diabetes in urban areas is associated with a 15.2% greater
smear-positive tuberculosis incidence and a 10.8% greater
total pulmonary tuberculosis incidence in urban com-
pared with rural areas. We estimate that the incidence of
smear-positive tuberculosis in urban areas is in fact 69.2%
greater than that in rural areas, from calculations using
measurements of the annual risk of tuberculosis infection,
suggesting that diabetes accounts for approximately a fifth
of the total difference.
Prevalence of diabetes among tuberculosis patients
We predict that in India 18.4% (12.5% to 29.9%) of peo-
ple with pulmonary tuberculosis (both smear-positive
and smear-negative) have diabetes, and that in the smear-
positive group diabetes prevalence is 23.5% (12.1% to
44%).
Discussion
Our findings suggest that a substantial proportion of inci-
dent tuberculosis in India is attributable to diabe-
tes;14.8% of pulmonary tuberculosis and 20.2% of
smear-positive – i.e. infectious – tuberculosis. They also
suggest that diabetes is present in 18.4% of adults in India
with pulmonary tuberculosis and in 23.5% of those with
smear-positive tuberculosis, despite a national adult dia-
betes prevalence of 4.3%. This result is comparable to that
of a recent study in Mexico, which found a diabetes prev-
alence of 35% among tuberculosis patients in a district
with an adult diabetes prevalence of 5.3%[5].
Estimates of the urban/rural distribution of the annual
risk of tuberculosis infection suggest that, on average,
smear-positive tuberculosis incidence in India is 69.2%
AF E
RR
RR
() =
− 1BMC Public Health 2007, 7:234 http://www.biomedcentral.com/1471-2458/7/234
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higher in urban compared with rural areas. Crowded liv-
ing conditions in urban districts are one possible factor.
However, the increased prevalence of diabetes in urban
areas may also play a role – according to our calculations,
diabetes is responsible for the urban incidence of smear-
positive tuberculosis being 15.2% greater than that in
rural areas, or approximately a fifth of the total difference.
Our results suggest therefore that the increased diabetes
prevalence associated with the rapid urbanization taking
place in India has important implications for tuberculosis
control.
Our findings are subject to the general caveats applied to
attributable risk estimates, for example that we assume a
causal association, that other risk factors for tuberculosis
are equally distributed across those with and without dia-
betes, and that those made more susceptible to infection
by diabetes are fully exposed to the tuberculosis risk. One
underlying risk factor for tuberculosis that may not be
equally distributed between those with and without dia-
betes in India is poverty. Consistent with this a recent case
control study from India of risk factors for TB found a uni-
variate odds ratio of 1.8 for previously diagnosed diabe-
tes, which strengthened to 2.44 when controlling for
other risk factors, including low socio economic sta-
tus[19]. However, even allowing for an uneven distribu-
tion in other risk factors between those with and without
diabetes our attributable risk estimates may well be con-
servative because our prevalence figures for diabetes are
conservative. A large study measuring the prevalence of
diabetes in urban areas in India reported that 12.1% of
adults had diabetes[10], compared with an urban preva-
lence of 5.6% found by the study used in our calcula-
tions[3]. Recalculating the Attributable Fraction
(Population) using this higher value suggests that in
urban areas this could be as high as 33.3% (7.4% to
64.2%) for pulmonary tuberculosis and 42.5% (19.0% to
66.2%) for smear-positive tuberculosis. Additionally, we
have not considered the contribution to tuberculosis risk
from hyperglycaemia below the diabetic threshold. Pub-
lished data on the association between non-diabetic
hyperglycaemia and tuberculosis are rare. However, a
recent case control study from Indonesia[24] reported an
odds ratio for the risk of tuberculosis associated with
impaired fasting glucose (4.2, 95% CIs 1.5–11.7) as simi-
lar to that for diabetes (4.7, 2.7 – 8.1). The prevalence of
impaired fasting glucose and of impaired glucose toler-
ance tend to be similar to or higher than the prevalence of
diabetes[8,10], and thus the overall impact of hypergly-
caemia may be even higher than our estimates presented
here suggest. Population-level measures for managing
hyperglycaemia may potentially be cost-effective simply
in terms of their benefit to tuberculosis control.
Limitations and strengths
A consequence of using separate studies for the different
estimates used in our calculations is an inability to
account for the inherent biases of each contributing study.
Table 2: Fraction of tuberculosis attributable to diabetes in India in 2000 in the adult population aged 25 years and over
Total pulmonary tuberculosis Smear-positive tuberculosis
Attributable Fraction 
(Population) % (upper and 
lower bounds)
Excess cases Percentage of 
excess cases
Attributable Fraction 
(Population) % (upper and 
lower bounds)
Excess cases Percentage of 
excess cases
Overall 
(crude)
15.1 (2.8 – 38.9) 141,548 - 20.8 (7.7 – 41.0) 119,622 -
Overall (age-
adjusted)
14.8 (7.1 – 23.8) 138,767 100.0 20.2 (8.3 – 41.9) 116,389 100.0
Women age 
in years:
25–29 12.5 (0.4 – 51.4) 7,455 5.4 10.6 (1.3 – 35.0) 3,683 3.2
30–39 23.9 (17.0 – 32.2) 21,926 15.8 16.5 (2.2 – 47.3) 8,993 7.7
40–49 14.9 (10.9 – 19.7) 7,316 5.3 35.4 (23.2 – 49.2) 11,016 9.5
50–59 6.2 (4.1 – 8.8) 1,755 1.3 17.6 (9.5 – 28.3) 3,112 2.7
60+ 5.0 (0.5 – 11.6) 982 0.7 17.0 (2.6 – 41.7) 2,128 1.8
Men age in 
years:
25–29 12.5 (0.4 – 51.4) 13,544 9.8 10.6 (1.3 – 35.0) 6,691 5.7
30–39 23.9 (17.0 – 32.2) 49,034 35.3 16.5 (2.2 – 47.3) 20,261 17.4
40–49 14.9 (10.9 – 19.7) 24,809 17.9 35.4 (23.2 – 49.2) 37,511 32.2
50–59 6.2 (4.1 – 8.8) 7,398 5.3 17.6 (9.5 – 28.3) 13,091 11.2
60+ 5.0 (0.5 – 11.6) 4,548 3.3 17.0 (2.6 – 41.7) 9,903 8.5BMC Public Health 2007, 7:234 http://www.biomedcentral.com/1471-2458/7/234
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However, so long as each of the studies is independently
valid, this does not invalidate our conclusions as long as
the assumptions involved are clearly understood.
In deciding on which study to use for the relative risk esti-
mates we searched thoroughly for studies describing the
association between tuberculosis and diabetes, and have
critically reviewed these studies elsewhere [25]. There is
consistent evidence from a number of studies, with differ-
ent designs and from geographically diverse areas that dia-
betes is associated with an increased risk of tuberculosis,
with an overall increased risk around 1.5 to 8 times
higher. However, there are several limitations in the pub-
lished studies, concerning in particular sample size, the
case definitions used for diabetes and tuberculosis, the
assessment and control for potential confounders and the
fact that most do not provide age specific relative risks or
odds ratios[25].
We chose to use relative risk estimates from the study in
Korea[17] for several reasons. Firstly, the lack of robust
studies reporting age specific relative risk estimates on the
association between diabetes and TB from India meant
that we had to look elsewhere. Secondly, the study from
Korea is the only genuine prospective cohort study on this
topic in the past 20 years, and thirdly it is one of only two
studies we found that provided age specific relative risk
estimates. In addition, based on chest X-rays at baseline
the study was able exclude reactivation of pulmonary TB
and assess the association of diabetes with new cases. It is,
however, important to acknowledge the study's shortcom-
ings. In particular the definition of diabetes was based on
unconventional glucose cut points (i.e. 150 mg/dl for fast-
ing and 180 mg/dl post prandial – as opposed to 140 and
200 mg/dl respectively as recommended by WHO at that
time). In addition, the diagnosis of diabetes was based on
glucose measurement at one point in time, rather than
repeated measurements to confirm the diagnosis. This is
common to virtually all epidemiological studies of diabe-
tes but is likely to result in significant misclassification of
cases of diabetes due to a mixture of biological variation
in blood glucose levels and measurement error. It is likely
that this led to an underestimate of the association
between diabetes and tuberculosis. The crude prevalence
of diabetes was low, being 1.2% in men and only 0.2% in
women, and there were only 3 women with diabetes (out
of 320) who developed TB, and thus sex and age specific
relative risk estimates were not available. A further limita-
tion is that there are likely to be underlying confounding
factors that we have not accounted for. One of these is
smoking, which is implicated as a risk factor for both dia-
betes and tuberculosis. Further work could include adjust-
ing the diabetes-associated risk of tuberculosis incidence
for the effect of smoking.
Nonetheless the study was large and well-structured, sim-
ilar age specific relative risk estimates were found by a
group working in Mexico[5], and the physiological mech-
anisms underlying diabetes-associated susceptibility are
unlikely to vary between populations.
Our finding that diabetes is more strongly related to smear
positive than smear negative TB reflects the greater relative
risks of diabetes for this form of TB found in the study
from Korea (see table 1). This relatively greater association
between diabetes and smear positive TB compared to
smear negative pulmonary TB, has been found in most,
but not all, studies that have addressed this issue [25]
The strengths of our study are that the estimates used are
taken from reliable, published sources, chosen after a con-
sideration of the available options, and we explore a new
hypothesis using a straightforward and transparent
method. Further, our study represents the first attempt we
are aware of to quantify the population impact of diabetes
on tuberculosis in India.
Table 3: Proportion of tuberculosis attributable to diabetes in the subpopulation of people with diabetes
Attributable Fraction (Exposed)
Total pulmonary tuberculosis %(upper and lower 
bounds)
Smear-positive tuberculosis % (upper and lower bounds)
Overall 80.5 (39.9 – 93.7) 85.9 (65.9 – 94.2)
Age in years
25–29 87.2 (15.3 – 98.1) 84.9* (39.4 – 96.2)
30–39 90.0 (85.4 – 93.1) 84.9* (39.4 – 96.2)
40–49 78.8 (72.1 – 83.9) 92.1 (86.6 – 95.4)
50–59 56.5 (45.4 – 65.5) 80.7 (67.4 – 88.5)
60+ 43.2 (6.5 – 65.6) 74.7 (27.5 – 91.2)
*As no relative risk (RR) was available for smear-positive tuberculosis incidence for the age band 25–29, the RR for the age band 30–39 was used.BMC Public Health 2007, 7:234 http://www.biomedcentral.com/1471-2458/7/234
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Implications
Currently, the future impact of tuberculosis control pro-
grammes is predicted from knowledge of the effects of
chemotherapy and how it is modified by the HIV epi-
demic. The findings we report indicate that diabetes also
has a considerable effect on tuberculosis epidemiology,
and so it is important to adapt tuberculosis programme
forecasts to incorporate additional risk factors.
The importance of the association between diabetes and
tuberculosis is highlighted by the immediate relevance to
the UN Millennium Development Goals, as it offers
opportunities for reducing the death rate from tuberculo-
sis, and improving its detection and treatment. It is widely
recognised that HIV makes a substantial contribution to
the global tuberculosis crisis. It is also known that cooper-
ation to target HIV and tuberculosis simultaneously is cru-
cial for the control of both diseases. In India, HIV
accounts for 3.4% of adult tuberculosis incidence[2]; the
proportion we estimate to be attributable to diabetes is
14.8%. The impact of diabetes on tuberculosis is therefore
already considerable, and the predictions of a diabetes
epidemic suggest this is likely to escalate.
In the past, an association between tuberculosis and dia-
betes was widely accepted. Indeed, half a century ago
expert clinics were established for "tuberculous diabetics"
and appeared to be successful in reducing the otherwise
high mortality rate[26]. Today, however, the potential
public health and clinical importance of this relationship
seems to be largely ignored. For example, national clinical
and policy guidance in the UK on the control of tubercu-
losis does not consider the relationship with diabetes[27].
The World Health Organization's new "Stop TB Strategy"
refers to the problem of TB in "high-risk groups" includ-
ing people with diabetes[28], but WHO has not yet made
specific recommendations concerning the relationship
between the two conditions. The recently published inter-
national standards for TB care give only cursory mention
to diabetes [29,30]. There are, however, some guidelines,
such as those from American Thoracic Society[31], which
explicitly recommend screening for latent tuberculosis in
patients with diabetes and a low threshold of investiga-
tion for tuberculosis in people with diabetes with unex-
plained symptoms. There is a need for new research to
guide policy and practice in this area. This includes the
need for robust studies of the association between the two
conditions, particularly from parts of the world such as
India where diabetes is increasing rapidly and TB remains
highly endemic. There is evidence that people with TB and
diabetes have worse TB outcomes than those without dia-
betes[25]. For example, a study from Indonesia found that
people with diabetes are more than twice as likely to
remain sputum culture positive at the end of treat-
ment[32]. The potential impact of diabetes on the success
of TB treatment and hence appropriate treatment strate-
gies for those with the two diseases deserves investigation
in other parts of the world. Another area worthy of inves-
tigation is the potential cost effectiveness of screening
people with diabetes for TB in highly endemic areas where
diabetes is now common.
Conclusion
We have illustrated, using data from India, that diabetes
makes a substantial contribution to tuberculosis inci-
dence. The current diabetes epidemic may lead to a resur-
gence of tuberculosis in endemic regions, especially in
urban areas. This has potentially serious implications for
tuberculosis control, and it must become a priority to use
this knowledge to initiate focused and coordinated action,
including new research in parts of the world where diabe-
tes is epidemic and TB endemic to properly inform public
health and clinical practice. It is time that the "unhealthy
partnership" [33]of tuberculosis and diabetes receives the
attention it deserves.
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